ArticleOncology letters2017

The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cells.

Kyoung Eun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.